True or false? Dimorphi fungi 1. Cryptococcus neoformans 2. Aspergillus
Reading File
Finding Sources
Finding Sources
Finding Sources
The textbooks confirm both answers. Here is the full breakdown:
Both statements are FALSE
1. Cryptococcus neoformans - FALSE (NOT dimorphic)
Cryptococcus neoformans is a monomorphic yeast - it exists only in the yeast (unicellular) form, both in the environment and in human tissue. It does NOT switch between mold and yeast forms.
- What makes it unique: it has a prominent polysaccharide capsule, produces melanin via laccase, and preferentially causes CNS infection (cryptococcal meningitis), especially in immunocompromised patients (CD4 < 100).
- The Sherris textbook explicitly separates Cryptococcus from the thermally dimorphic fungi: "The thermally dimorphic fungi each have distinctive tissue forms... Cryptococcus neoformans - Capsule, CD4 cell dysfunction predisposes..." - it lists Cryptococcus alongside but distinct from dimorphic fungi.
- Fishman's Pulmonary Diseases similarly notes: "The dimorphic fungi Histoplasma, Blastomyces, and Coccidioides AND the yeast Cryptococcus neoformans share epidemiologic characteristics" - notably placing Cryptococcus as a yeast, not a dimorphic fungus.
2. Aspergillus - FALSE (NOT dimorphic)
Aspergillus is a monomorphic mold - it grows as septate hyphae with characteristic conidiophores, both in the environment and in human tissue. It never converts to a yeast form.
- Robbins Pathology explicitly categorizes Aspergillus under "Mold Infections" and lists "Dimorphic Fungal Infections" as a completely separate category (Histoplasmosis, Blastomycosis, Coccidioidomycosis).
- Tietz Laboratory Medicine defines dimorphic as: "displaying two morphologic forms... mainly reserved for fungi that exhibit thermal dimorphism resulting in hyphal forms in nature (or at room temperature) and yeast forms in human tissues." Aspergillus does not do this - it remains a mold in tissue.
The TRUE Dimorphic Fungi (for reference)
The classic thermally dimorphic fungi are: Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis/posadasii, Paracoccidioides brasiliensis, Sporothrix schenckii, and Talaromyces (Penicillium) marneffei. These all follow the rule: mold in the cold (environment/room temp), yeast in the heat (human body/37°C) - except Coccidioides, which forms spherules (not yeast) in tissue.
Candida?
Finding Sources
Finding Sources
Candida as a Dimorphic Fungus - FALSE (but with important nuance)
Candida is NOT classified as a dimorphic fungus in the classic/traditional sense. Here's why:
Why Candida is NOT "dimorphic" (classically)
Classic dimorphism = thermal dimorphism:
- Mold at room temperature (25-30°C)
- Yeast at body temperature (37°C)
- Examples: Histoplasma, Blastomyces, Coccidioides, Paracoccidioides, Sporothrix
Candida does not follow this rule. It starts as a yeast and remains a yeast as its baseline form. It is categorized as an opportunistic yeast, not a classic dimorphic fungus. Textbooks (Robbins, Sherris, Harrison's) consistently list Candida under "Yeast Infections" separately from "Dimorphic Fungal Infections."
The nuance - Candida IS polymorphic
Candida albicans (and some other species) can switch between morphological forms depending on environmental signals (pH, CO2, temperature, nutrients), not strictly temperature:
| Form | Seen when |
|---|---|
| Yeast (blastoconidia) | Colonization of mucosal surfaces, dissemination in blood |
| Pseudohyphae | Tissue invasion, infection |
| True hyphae | Invasive infection (most virulent form) |
| Chlamydospores | Adverse/nutrient-poor conditions |
As Tietz states: "The yeast forms colonize mucosal surfaces... True hyphae play a role in virulence through adhesion and tissue invasion."
This switching is called polymorphism (or phenotypic switching), and it IS a virulence factor - but it is not the same as classic thermal dimorphism.
Bottom line
| Organism | Classification |
|---|---|
| Histoplasma, Blastomyces, Coccidioides | TRUE dimorphic (thermal) |
| Cryptococcus | Monomorphic yeast |
| Aspergillus | Monomorphic mold |
| Candida | Polymorphic yeast (yeast + pseudohyphae + hyphae) - NOT classically dimorphic |
So in an exam context: Candida = FALSE for dimorphic fungi. If asked about its morphology, the key point is its ability to form germ tubes and hyphae, which is a virulence mechanism - not thermal dimorphism.
Aspergillus speciesa) are dimorphic fungib) can cause allergic bronchopulmonary aspergillosis in immunocompetent peoplec) cause disseminated infection in immunocompromised patientsd) isolation from sputum expectorate is a reliable test to confirm the diagnosis of aspergilloma.e) infection is treated with voriconazole
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Here is the full breakdown of each statement:
Aspergillus species - True or False?
a) Are dimorphic fungi - FALSE
Aspergillus is a monomorphic mold. It grows as septate hyphae with characteristic conidiophores both in the environment and in human tissue - it never converts to a yeast form. Classic dimorphic fungi (Histoplasma, Blastomyces, Coccidioides, etc.) are an entirely separate category. Robbins Pathology lists Aspergillus under "Mold Infections" and "Dimorphic Fungal Infections" as completely separate sections.
b) Can cause ABPA in immunocompetent people - TRUE
ABPA is a hypersensitivity reaction (Type I + Type III), not an infection. It occurs in immunocompetent patients who are atopic - specifically those with:
- Asthma (~2.5% of asthmatics develop ABPA)
- Cystic fibrosis
As Murray & Nadel's states: "Predisposing condition: asthma or cystic fibrosis." The mechanism is an exaggerated Th2 response (IgE, IgG, eosinophilia) to inhaled A. fumigatus antigens - no immunosuppression needed. In fact, immunocompromised patients typically get invasive aspergillosis, NOT ABPA.
Key features of ABPA: fever, wheezing, eosinophilia, central bronchiectasis, fleeting pulmonary opacities, IgE >1000 IU/mL.
c) Cause disseminated infection in immunocompromised patients - TRUE
Invasive/disseminated aspergillosis is the hallmark disease in immunocompromised patients - particularly those with:
- Prolonged neutropenia (e.g. post-chemotherapy, stem cell transplant)
- High-dose corticosteroids
- Advanced HIV
Aspergillus (especially A. fumigatus) invades blood vessels causing angioinvasion, infarction, and haematogenous dissemination to brain, kidneys, heart, and skin. Goldman-Cecil: "Treatment of invasive aspergillosis relies on a triad of antifungal therapy, reversal of immunosuppression, and surgical resection."
d) Sputum culture confirms aspergilloma diagnosis - FALSE
Sputum culture is unreliable for aspergilloma. As Fishman's Pulmonary Diseases states directly:
"Although sputum cultures are positive for Aspergillus in more than half of all patients with aspergilloma, culture is not a sensitive and specific diagnostic marker."
The reasons:
- Aspergillus is a common environmental contaminant - a positive culture could just mean colonisation or lab contamination
- A negative culture does not rule it out
Reliable diagnosis of aspergilloma relies on:
- Chest CT/X-ray - fungus ball (hyphal mass) within a cavity with the "Monod sign" (air crescent sign)
- Serum precipitating antibodies (IgG) - present in >95% of aspergilloma patients
- BAL or lung biopsy in atypical cases
e) Infection is treated with voriconazole - TRUE
Voriconazole is the first-line treatment for invasive aspergillosis. Katzung's Pharmacology states: "Voriconazole is less toxic than amphotericin B and is the treatment of choice for invasive aspergillosis."
Goldman-Cecil confirms: "Voriconazole or isavuconazole is recommended as the preferred agents, but posaconazole and liposomal amphotericin B are alternatives."
Note however:
- Aspergilloma (fungus ball) - antifungals have limited penetration; surgery (resection) is often preferred for symptomatic cases
- ABPA - treated primarily with corticosteroids (itraconazole or voriconazole used as steroid-sparing adjuncts)
- Invasive aspergillosis - voriconazole is definitively first-line
Summary Table
| Statement | Answer | |
|---|---|---|
| a | Dimorphic fungus | FALSE |
| b | ABPA in immunocompetent | TRUE |
| c | Disseminated in immunocompromised | TRUE |
| d | Sputum culture confirms aspergilloma | FALSE |
| e | Treated with voriconazole | TRUE |
This is a shared conversation. Sign in to Orris to start your own chat.